The global market for OPO-containing Infant Formulas was valued at US$ 1020 million in the year 2023 and is projected to reach a revised size of US$ 1433 million by 2030, growing at a CAGR of 5.0% during the forecast period.
OPO-containing infant formulas are specialized formulas enriched with structured triglycerides, predominantly 1,3-dioleoyl-2-palmitoylglycerol (OPO), designed to mimic the fat structure of human breast milk. OPO enhances the bioavailability of palmitic acid in a way that promotes better fat and calcium absorption, reducing the risk of constipation and improving stool consistency in infants. Key features include a balanced lipid profile, enhanced digestibility, and a role in supporting gut health by fostering beneficial microbiota. These formulas are particularly beneficial for infants who cannot be breastfed, offering improved energy utilization, growth support, and comfort in digestion, making them suitable for addressing feeding issues and ensuring optimal nutrient uptake.
North American market for OPO-containing Infant Formulas is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for OPO-containing Infant Formulas is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of OPO-containing Infant Formulas include BiosTime, Nutriben, Ausnutria, HERDS, Milupa, Shanxi Yatai, Beingmate, Abbott, Brightdairy, Feihe, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for OPO-containing Infant Formulas, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OPO-containing Infant Formulas.
The OPO-containing Infant Formulas market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global OPO-containing Infant Formulas market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OPO-containing Infant Formulas manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BiosTime
Nutriben
Ausnutria
HERDS
Milupa
Shanxi Yatai
Beingmate
Abbott
Brightdairy
Feihe
Wyeth Nutrition
Deloraine
Yili
Kabrita
by Type
Cow Milk Formula
Goat Milk Formula
by Application
0 - 6 Month
6 - 12 Month
12 - 36 Month
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Southeast Asia
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of OPO-containing Infant Formulas manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of OPO-containing Infant Formulas in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 OPO-containing Infant Formulas Market Overview
1.1 Product Definition
1.2 OPO-containing Infant Formulas by Type
1.2.1 Global OPO-containing Infant Formulas Market Value Comparison by Type (2024-2030)
1.2.2 Cow Milk Formula
1.2.3 Goat Milk Formula
1.3 OPO-containing Infant Formulas by Application
1.3.1 Global OPO-containing Infant Formulas Market Value by Application (2024-2030)
1.3.2 0 - 6 Month
1.3.3 6 - 12 Month
1.3.4 12 - 36 Month
1.4 Global OPO-containing Infant Formulas Market Size Estimates and Forecasts
1.4.1 Global OPO-containing Infant Formulas Revenue 2019-2030
1.4.2 Global OPO-containing Infant Formulas Sales 2019-2030
1.4.3 Global OPO-containing Infant Formulas Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 OPO-containing Infant Formulas Market Competition by Manufacturers
2.1 Global OPO-containing Infant Formulas Sales Market Share by Manufacturers (2019-2024)
2.2 Global OPO-containing Infant Formulas Revenue Market Share by Manufacturers (2019-2024)
2.3 Global OPO-containing Infant Formulas Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of OPO-containing Infant Formulas, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of OPO-containing Infant Formulas, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of OPO-containing Infant Formulas, Product Type & Application
2.7 Global Key Manufacturers of OPO-containing Infant Formulas, Date of Enter into This Industry
2.8 Global OPO-containing Infant Formulas Market Competitive Situation and Trends
2.8.1 Global OPO-containing Infant Formulas Market Concentration Rate
2.8.2 The Global 5 and 10 Largest OPO-containing Infant Formulas Players Market Share by Revenue
2.8.3 Global OPO-containing Infant Formulas Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global OPO-containing Infant Formulas Market Scenario by Region
3.1 Global OPO-containing Infant Formulas Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global OPO-containing Infant Formulas Sales by Region: 2019-2030
3.2.1 Global OPO-containing Infant Formulas Sales by Region: 2019-2024
3.2.2 Global OPO-containing Infant Formulas Sales by Region: 2025-2030
3.3 Global OPO-containing Infant Formulas Revenue by Region: 2019-2030
3.3.1 Global OPO-containing Infant Formulas Revenue by Region: 2019-2024
3.3.2 Global OPO-containing Infant Formulas Revenue by Region: 2025-2030
3.4 North America OPO-containing Infant Formulas Market Facts & Figures by Country
3.4.1 North America OPO-containing Infant Formulas Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America OPO-containing Infant Formulas Sales by Country (2019-2030)
3.4.3 North America OPO-containing Infant Formulas Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe OPO-containing Infant Formulas Market Facts & Figures by Country
3.5.1 Europe OPO-containing Infant Formulas Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe OPO-containing Infant Formulas Sales by Country (2019-2030)
3.5.3 Europe OPO-containing Infant Formulas Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific OPO-containing Infant Formulas Market Facts & Figures by Region
3.6.1 Asia Pacific OPO-containing Infant Formulas Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific OPO-containing Infant Formulas Sales by Region (2019-2030)
3.6.3 Asia Pacific OPO-containing Infant Formulas Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Southeast Asia
3.6.10 Vietnam
3.7 Latin America OPO-containing Infant Formulas Market Facts & Figures by Country
3.7.1 Latin America OPO-containing Infant Formulas Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America OPO-containing Infant Formulas Sales by Country (2019-2030)
3.7.3 Latin America OPO-containing Infant Formulas Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa OPO-containing Infant Formulas Market Facts & Figures by Country
3.8.1 Middle East and Africa OPO-containing Infant Formulas Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa OPO-containing Infant Formulas Sales by Country (2019-2030)
3.8.3 Middle East and Africa OPO-containing Infant Formulas Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global OPO-containing Infant Formulas Sales by Type (2019-2030)
4.1.1 Global OPO-containing Infant Formulas Sales by Type (2019-2024)
4.1.2 Global OPO-containing Infant Formulas Sales by Type (2025-2030)
4.1.3 Global OPO-containing Infant Formulas Sales Market Share by Type (2019-2030)
4.2 Global OPO-containing Infant Formulas Revenue by Type (2019-2030)
4.2.1 Global OPO-containing Infant Formulas Revenue by Type (2019-2024)
4.2.2 Global OPO-containing Infant Formulas Revenue by Type (2025-2030)
4.2.3 Global OPO-containing Infant Formulas Revenue Market Share by Type (2019-2030)
4.3 Global OPO-containing Infant Formulas Price by Type (2019-2030)
5 Segment by Application
5.1 Global OPO-containing Infant Formulas Sales by Application (2019-2030)
5.1.1 Global OPO-containing Infant Formulas Sales by Application (2019-2024)
5.1.2 Global OPO-containing Infant Formulas Sales by Application (2025-2030)
5.1.3 Global OPO-containing Infant Formulas Sales Market Share by Application (2019-2030)
5.2 Global OPO-containing Infant Formulas Revenue by Application (2019-2030)
5.2.1 Global OPO-containing Infant Formulas Revenue by Application (2019-2024)
5.2.2 Global OPO-containing Infant Formulas Revenue by Application (2025-2030)
5.2.3 Global OPO-containing Infant Formulas Revenue Market Share by Application (2019-2030)
5.3 Global OPO-containing Infant Formulas Price by Application (2019-2030)
6 Key Companies Profiled
6.1 BiosTime
6.1.1 BiosTime Company Information
6.1.2 BiosTime Description and Business Overview
6.1.3 BiosTime OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2019-2024)
6.1.4 BiosTime OPO-containing Infant Formulas Product Portfolio
6.1.5 BiosTime Recent Developments/Updates
6.2 Nutriben
6.2.1 Nutriben Company Information
6.2.2 Nutriben Description and Business Overview
6.2.3 Nutriben OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Nutriben OPO-containing Infant Formulas Product Portfolio
6.2.5 Nutriben Recent Developments/Updates
6.3 Ausnutria
6.3.1 Ausnutria Company Information
6.3.2 Ausnutria Description and Business Overview
6.3.3 Ausnutria OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Ausnutria OPO-containing Infant Formulas Product Portfolio
6.3.5 Ausnutria Recent Developments/Updates
6.4 HERDS
6.4.1 HERDS Company Information
6.4.2 HERDS Description and Business Overview
6.4.3 HERDS OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2019-2024)
6.4.4 HERDS OPO-containing Infant Formulas Product Portfolio
6.4.5 HERDS Recent Developments/Updates
6.5 Milupa
6.5.1 Milupa Company Information
6.5.2 Milupa Description and Business Overview
6.5.3 Milupa OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Milupa OPO-containing Infant Formulas Product Portfolio
6.5.5 Milupa Recent Developments/Updates
6.6 Shanxi Yatai
6.6.1 Shanxi Yatai Company Information
6.6.2 Shanxi Yatai Description and Business Overview
6.6.3 Shanxi Yatai OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Shanxi Yatai OPO-containing Infant Formulas Product Portfolio
6.6.5 Shanxi Yatai Recent Developments/Updates
6.7 Beingmate
6.7.1 Beingmate Company Information
6.7.2 Beingmate Description and Business Overview
6.7.3 Beingmate OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Beingmate OPO-containing Infant Formulas Product Portfolio
6.7.5 Beingmate Recent Developments/Updates
6.8 Abbott
6.8.1 Abbott Company Information
6.8.2 Abbott Description and Business Overview
6.8.3 Abbott OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Abbott OPO-containing Infant Formulas Product Portfolio
6.8.5 Abbott Recent Developments/Updates
6.9 Brightdairy
6.9.1 Brightdairy Company Information
6.9.2 Brightdairy Description and Business Overview
6.9.3 Brightdairy OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Brightdairy OPO-containing Infant Formulas Product Portfolio
6.9.5 Brightdairy Recent Developments/Updates
6.10 Feihe
6.10.1 Feihe Company Information
6.10.2 Feihe Description and Business Overview
6.10.3 Feihe OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Feihe OPO-containing Infant Formulas Product Portfolio
6.10.5 Feihe Recent Developments/Updates
6.11 Wyeth Nutrition
6.11.1 Wyeth Nutrition Company Information
6.11.2 Wyeth Nutrition Description and Business Overview
6.11.3 Wyeth Nutrition OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Wyeth Nutrition OPO-containing Infant Formulas Product Portfolio
6.11.5 Wyeth Nutrition Recent Developments/Updates
6.12 Deloraine
6.12.1 Deloraine Company Information
6.12.2 Deloraine Description and Business Overview
6.12.3 Deloraine OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Deloraine OPO-containing Infant Formulas Product Portfolio
6.12.5 Deloraine Recent Developments/Updates
6.13 Yili
6.13.1 Yili Company Information
6.13.2 Yili Description and Business Overview
6.13.3 Yili OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Yili OPO-containing Infant Formulas Product Portfolio
6.13.5 Yili Recent Developments/Updates
6.14 Kabrita
6.14.1 Kabrita Company Information
6.14.2 Kabrita Description and Business Overview
6.14.3 Kabrita OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Kabrita OPO-containing Infant Formulas Product Portfolio
6.14.5 Kabrita Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 OPO-containing Infant Formulas Industry Chain Analysis
7.2 OPO-containing Infant Formulas Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 OPO-containing Infant Formulas Production Mode & Process
7.4 OPO-containing Infant Formulas Sales and Marketing
7.4.1 OPO-containing Infant Formulas Sales Channels
7.4.2 OPO-containing Infant Formulas Distributors
7.5 OPO-containing Infant Formulas Customers
8 OPO-containing Infant Formulas Market Dynamics
8.1 OPO-containing Infant Formulas Industry Trends
8.2 OPO-containing Infant Formulas Market Drivers
8.3 OPO-containing Infant Formulas Market Challenges
8.4 OPO-containing Infant Formulas Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
BiosTime
Nutriben
Ausnutria
HERDS
Milupa
Shanxi Yatai
Beingmate
Abbott
Brightdairy
Feihe
Wyeth Nutrition
Deloraine
Yili
Kabrita
听
听
*If Applicable.